Vol. 10, No. 46
Covering Cases Published in the Advance Sheets through November 17, 2003

Note: This Visitor's version of Punch and Jurists does not include all the cases covered in the Member's version. In addition, while the Member's version contains links to the full text of all of the decisions noted below, that feature is not available in the Visitor's Edition. Thus, while the names of some of the cases cited below may be highlighted in blue, they are not hypertext-linked to the official decision in this Visitor's Edition of Punch and Jurists.

Supreme Court

Guidelines

Evidence of Prior Crimes - The Different Standards for Defendants and Witnesses

Apprendi Rule


U.S. v. Landa, 281 F.Supp.2d 1139 (N.D.Cal. 2003) (Judge Alsup)

After the three defendants in this case were charged with participating in a “large-scale” marijuana-cultivation venture, they pled guilty to maintaining a place for the manufacturing of marijuana, in violation of 21 U.S.C. § 856(a)(1). Their plea agreements allowed them to seek a downward departure on the grounds that they were growing “medical marijuana.”

As support for such a departure, the defendants first cited U.S. v. Rosenthal, 266 F.Supp.2d 1091 (N.D.Cal. June 9, 2003), where Judge Breyer had sentenced a defendant, who was convicted of cultivating medical marijuana, to one day in prison, with credit for time served.

Judge Alsup held that the Rosenthal decision was inapplicable to the facts of the instant case principally because (a) the defendant in that case was eligible for a safety-valve sentence reduction, whereas all three defendants in the instance case had prior criminal narcotics records, making them ineligible for a similar sentence reduction; and (b) the defendant in that case believed (albeit wrongly) that an ordinance passed by the Oakland City Council had expressly immunized him from both state and Federal prosecution. (Id., at 1142).

The defendants also argued that their operation was lawful under Cal. Health & Safety Code § 11362.5 because all of the marijuana was grown for medicinal purposes. The Court noted that the defendants had leased a large commercial space and used it to grow more than 1,245 rooted marijuana plants, using electric grow lamps, an irrigation drip system, and chemicals and fertilizer; and it held that § 11362.5 did not immunize large-scale growing operations intended to distribute marijuana. The Court also held that, even though it found that a substantial part of the marijuana was intended to be used as medicine, a downward departure was not warranted because, given the absence of inventory controls and the absence of clear-cut distribution commitments for medicinal use of the marijuana, it was hard to conclude that all of the inventory would have found its way exclusively for medicinal purposes.

Finally, the defendants argued that they were entitled to a downward departure because they desired to avoid a “lesser harm,” namely the pain and suffering that they and others will endure if they are denied medical marijuana. (Id., at 1143, citing U.S.S.G. § 5K2.11). The Court rejected that departure ground, noting that, even if all of the marijuana was firmly destined for qualified sick patients, the conduct was still a willful violation of federal law. It then concluded: “To allow a reduced sentence for medical marijuana grown in willful violation of federal law would, by reducing the penalty, reduce the deterrent effect and thereby undermine the federal interest in eradicating all forms of marijuana, medical or otherwise. . . . To do so, however, would pose a substantial risk of encouraging the very type of conduct Congress has sought to stop. Accordingly, the policy statement [U.S.S.G. § 5K2.11] . . . specifically bars the requested departure.” (Id., at 1145).


U.S. v. Toliver, No. 01-10222 (9th Cir. 12/03/2003) (Judge Paez)

In this case, the Court considered the consequences when a district court properly complies with Apprendi v. New Jersey, 530 U.S. 466 (2000) by instructing the jury to return special findings on the quantity and type of drugs involved in the drug conspiracy at issue, but the jury, although finding the defendants guilty of conspiracy and attempted possession of a controlled substance, is unable to reach a verdict on the questions of drug type and quantity.


Under those circumstances, the defendants (who were sentenced to 168 and 152 months in prison) argued that they were entitled to a judgment of acquittal because the drug quantity and type determination were “elements” of the crime that was charged which were not proven beyond a reasonable doubt as required by Apprendi and by In re Winship, 397 U.S. 358 (1970).

The Court disagreed, stating that there is a difference between a “formal offense element” as defined in Winship and the “functional equivalent of an element” under Apprendi. It stated that drug quantity and type determinations were “the ‘functional equivalents of a greater offense,’ because they are facts that have the potential to increase the statutory maximum sentence. For purposes of Apprendi, then, these facts must be submitted to the jury, as was done here. . . . [However], attaching the label ‘element’ to a fact that may increase the maximum statutory sentence only has significance for purposes of satisfying the due process rights established by Apprendi.”

Applying those principles, the Court reasoned that the defendants were not entitled to a judgment of acquittal “merely because the government had the foresight to include specific quantities and types of drugs” in the indictment and the jury was unable to agree on those factors. It said that the jury had determined that the defendants had engaged in a conspiracy and an attempt to possess and distribute an unknown quantity of cocaine, “all that is required for a conviction under 21 U.S.C. §§ 846, 841(a) and 18 U.S.C. § 2.”

Thus, the Court concluded: “The jury’s inability to determine the quantity or type of drugs involved in the conspiracy did not justify an acquittal; it only prevented the district court from imposing a sentence that exceeded 20 years, the maximum allowable sentence under 841(b)(1)(C) when the offense involves an unknown quantity of drugs.”


In Brief

DNA Analysis Backlog Elimination Act Upheld: Vore v. U.S. Dept. of Justice, 281 F.Supp.2d 1129 (D.Ariz. 2003) - Here, citing a comprehensive and up-to-date list of decisions that have upheld the constitutionality of the DNA Analysis Backlog Elimination Act (42 U.S.C. §§ 14135(a)-14135(e)) (the “DNA Act”), the Court rejected a broad range of challenges to that Act, holding that the DNA Act served at least two valid purposes which it said were “beyond the normal need for law enforcement” (namely, the creation of a more accurate criminal justice system and the creation of a more complete DNA database), and that the suspicionless searches were justified under the “special needs” exception to the Fourth Amendment.


The Average Wait for Criminal Trials

According to www.uscourts.gov, the average time that criminal defendants who are released on bail must wait for their trials to start varies considerably depending on where the defendant is indicted. Here are the figures:

CIRCUIT
AVG. WAIT - IN DAYS
CIRCUIT
AVG. WAIT - IN DAYS
First
255.0
Seventh
217.7
Second
350.5 (1)
Eighth
215.2
Third
263.8
Ninth
220.5
Fourth
197.3
Tenth
169.7 (2)
Fifth
196.4
Eleventh
190.6
Sixth
219.8
(1) Longest wait -  (2) Shortest wait

 


Scorecard Of Published Federal Criminal Cases Reviewed By Our Staff:

Court

This Week

Year to Date

Since 1996

Courts of Appeal

18

2,170

18,678

District Courts

27

1,332

 10,270


Copyright © 2003 Punch and Jurists, Ltd.